Research Press Release
June 23, 2023
Our project is featured in the Research News of Hokkaido University! Please click the link below.
Combination therapy effective against canine melanoma – Hokkaido University
We have shown that a combination of radiotherapy followed by immunotherapy using anti-PD-L1 antibody is a promising strategy for the treatment of oral malignant melanomas in dogs. The finding was published in Cancers.
This release is related to the original article below:
Deguchi T, Maekawa N, Konnai S, Owaki R, Hosoya K, Morishita K, Nakamura M, Okagawa T, Takeuchi H,
Kim S, Kinoshita R, Tachibana Y, Yokokawa M, Takagi S, Kato Y, Suzuki Y, Murata S, Ohashi K
Enhanced systemic antitumour immunity by hypofractionated radiotherapy and
anti-PDL1 therapy in dogs with pulmonary metastatic oral malignant melanoma
Cancers, 2023, 15(11): 3013
https://www.mdpi.com/2072-6694/15/11/3013 (open access)
Please check our previous press release if you are interested in the history of our study.
New therapy target for malignant melanomas in dogs (Research Press Release, April 22, 2021)
New therapeutic antibody for dog cancers (Research Press Release, August 25, 2017)
Treatment strategies in this clinical study
The effect of the combination therapy against canine pulmonary oral malignant melanoma
A clinical research team of this study
Website of Hokkaido University (as of 2023/6/23 12:30, https://www.global.hokudai.ac.jp/)
Research Press Releases
December 22, 2022
Predicting the onset of bovine lymphoma ― Development of cancer screening technology
April 22, 2021
New therapy target for malignant melanomas in dogs
April 2, 2021
Probiotics keep calves healthy, too!
January 29, 2021
Deeper insight into how tick spit suppresses cattle immunity
August 2, 2019
The drug combination effective against bovine leukemia
April 2, 2018
Unraveling the immunopathogenesis of Johne’s disease
August 25, 2017
New therapeutic antibody for dog cancers
June 7, 2017
Overcoming immune suppression to fight against bovine leukemia